Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2004Journal of Medicinal ChemistryOpen Access

N-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N-5-[[[5-(1,1-Dimethylethyl)-2-oxazolylmethyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent

View Full Paper
Ask AI
Bookmark
Share

Authors

RMRaj N. MisraRutgers, The State University of New JerseyHXHai‐Yun XiaoBristol-Myers Squibb (Germany)KKKyoung S. KimBristol-Myers Squibb (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Misra et al. (2004) studied this question.

synapsesocial.com/papers/6a830cc49ee9542cd6efdfd4https://doi.org/10.1021/jm0305568
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types1994 · 2,798 citations
  2. 2Effects of Folate Deficiency and Supplementation on Methylnitrosourea-Induced Rat Mammary Tumors1992 · 93 citations
  3. 3Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.1998 · 409 citations
  4. 4Electrolytic Oxidation of Ketones in Ammoniacal Methanol in the Presence of Catalytic Amounts of KI1995 · 33 citations
  5. 5Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-82751992 · 353 citations